Covance Is Now Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Learn More

Blog Posts

Maximizing Real-World Data: Impact of Cardiovascular Disease on Clinical Outcomes in Rheumatoid Arthritis

Current guidance on rheumatoid arthritis (RA) stresses the importance of considering comorbidity when assessing disease activity and making clinical decisions. Comorbidities commonly associated with RA include cardiovascular disease (CVD), lung disease and malignancy. Covance is committed to advancing RA clinical trials in partnerships that will further the understanding and improvement of treatments in RA.